Zdrowie i gospodarka · 07/03/2016

FDA Announces Draft Guidance for Investigational Device Exemptions for Neurological Devices

The FDA has released a draft guidance to help sponsors prepare for clinical trials on neurological devices targeting disease progression and clinical outcomes, with the goal of improving patient-centered care.